ABSTRACT: A select committee of Britain's House of Lords this week accused the Medicines Control Agency of not dealing with cannabis based medicines in the same impartial manner as it dealt with other medicines. In its report it said that the agency's insistence that new toxicology data were needed on one of the 60 cannabinoids present in raw cannabis would delay the approval ... Continue Reading